<DOC>
	<DOCNO>NCT03069521</DOCNO>
	<brief_summary>Prospective , feasibility study evaluate safety EndoArt™ treatment 12 subject suffer corneal edema . Followed 12 month .</brief_summary>
	<brief_title>Study Evaluate Safety EndoArt™ Treatment Subjects Suffering From Corneal Edema</brief_title>
	<detailed_description>Title : Prospective , feasibility study evaluate safety EndoArt™ treatment subject suffer corneal edema Device : EndoArt™ ( Artificial Endothelial Layer ) Intended Use : The EndoArt™ device intend use endothelial kearatoprosthesis patient chronic cornel edema Study Design : Prospective open-label feasibility clinical study Study Objectives : To evaluate safety EndoArt™ implant subject suffer corneal edema . Study Hypothesis : Treatment EndoArt™ safe may result alleviate symptom result chronic corneal edema ( corneal thickness ) . Study population : Men woman suffer decrease vision due chronic corneal edema meet inclusion/exclusion criterion provide write Informed Consent enrol study . Enrollment : A total 12 subject enrol . Study Duration : Completion active enrolment anticipate last approximately 12 month . The primary end point achieve final study subject complete 6 month follow . Subject follow 12 month . Primary Safety Endpoint : The frequency severity treatment-related adverse event , implantation EndoArt™ throughout 6 month follow-up period . Adverse event assess continuous basis procedure study completion 6 month . Related adverse event include : corneal perforation , melt , uncontrolled inflammation , severe infection . Secondary Efficacy Endpoints : Corneal thickness , Subjective corneal clarity , Pain assess Visual Analogue Scale ( VAS ) Measurement Best Corrected Distance Visual Acuity ( BCDVA ) Study Treatment : Subjects implant EndoArt™</detailed_description>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Corneal Edema</mesh_term>
	<criteria>1 . Subject 50 year old 2 . Subject chronic corneal edema . 3 . Subject corneal thickness &gt; 650 µm 4 . Subject visual acuity 6/60 worse ( equivalent ETDRS ) low visual potential due e.g . : AMD , macula scar , optic nerve atrophy etc . addition chronic corneal edema . 5 . Subject well visual acuity contralateral eye . 6 . Pseudophakic subject ( anterior posterior ) stable IOL . 7 . Subject understands study requirement treatment procedure provide write Informed Consent studyspecific test procedure perform . 1 . Subject best correct visual acuity 6/24 bad fellow eye 2 . Subject history ocular Herpes keratitis 3 . Subject severely scarred cornea ( unfit regular endothelial keratoplasty ) 4 . Subject irregular posterior cornea ( e.g . post PKP ) 5 . Subject suffer infection cornea 6 . Patients band keratopathy and/or limbal stem cell deficiency . 7 . Subject moderate severe dry eye 8 . Subject phthisis phthisis suspect 9 . Subject low ocular pressure ≤6 mmHg high 25 mmHg . 10 . Subject aphakica 11 . Subject pseudophakodonesis 12 . Subject large iris defect compromise intraoperative AC stability . 13 . Subjects corneal refractive surgery . 14 . Subject glaucoma shunt ( e.g . Ahmend valve ) 15 . Subject neurotrophic corneal history 16 . Subject history persistent corneal erosion difficulty epithelial growth ( reepithelization ) 17 . Subject currently participate participate investigational study , study , within past 60 day</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>